Class IIIReported 2025-10-22
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
Recalled by Endo USA, Inc.
Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Advertisement
Recall NumberD-0026-2026ClassificationClass IIIStatusOngoingCategorydrugInitiated2025-09-05Reported2025-10-22DistributionNationwide within the United StatesCode InfoLot #: 550172301, Exp. Date January 2026Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.